Daily Dose: Semaglutide 2.4 mg and Long-term Weight Loss
Your daily dose of clinical news you may have missed.
CDC Releases First Estimates of Bivalent mRNA COVID-19 Booster Effectiveness against XBB/XBB.1.5
Preliminary estimates showed relative bivalent booster dose vaccine effectiveness against XBB/XBB.1.5 for at least the first 3 months after vaccination.
Dementia Risk in Older Women Reduced with More Vigorous Physical Activity, More Daily Steps
Accelerometer-measured physical activity and steps were associated with as much as a 60% lower risk of Alzheimer's disease and related dementias in a new study.
Declining Kindergarten Vaccination Rate Leaves 250k Children Unprotected: AAFP President's Perspective
Tochi Iroku-Malize, MD, MPH, MBA, converts the 93% immunization rate for US kindergarteners into raw numbers of children now vulnerable to vaccine-preventable disease.
Daily Dose: Improved Glycemic Control and NAFLD in Type 2 Diabetes
Cannabis Legalization and Prenatal Marijuana Use: Pregnant Women Describe Impact
New research offers insight into how women who use cannabis during pregnancy perceive the impacts of cannabis legalization.
Semaglutide 2.4 mg Sustains Long-term Weight Loss by Reducing Cravings, Appetite: New Analysis
Sustained weight loss with semaglutide 2.4 mg is a result of the drug's effects on control of eating, including reduced cravings and hunger and increased satiety, study authors write.
Daily Dose: HDL-C and Fracture Risk in Older Adults
FDA Approves SGLT2 Inhibitor Bexagliflozin to Treat Type 2 Diabetes in Adults
Bexagliflozin significantly improved glycemic control in adults when used as monotherapy, in combination with metformin, or when added to several SOC regimens.
Improved HbA1c in Adults with T2D Had Beneficial Impact on NAFLD, According to New Study
Adults with T2D may be able to reduce their liver fat and improve their liver fibrosis stage with reductions in HbA1c, according to findings from a retrospective analysis.
Metformin Treatment in T2D Patients May Reduce Risk for Joint Replacement: Population-based Study
Investigators report a 30% reduced risk of total joint replacement in persons with type 2 diabetes treated with metformin vs those who did not receive the drug.
Record Proportion of Americans Delay Medical Care due to Cost in 2022: Survey
Americans are putting off care, even for serious conditions, because of cost. Inflation may have driven the numbers to an all time high, a new survey suggests.
Daily Dose: Pediatric Cannabis Poisoning Surges
Gestational Diabetes and Maternal Obesity Have “Unfavorable” Effects on Neurodevelopment in Children
An overall good quality of diet and higher fish intake during pregnancy were related to better language skills in 2-year-old children, according to new study.
Elevated HDL-C May be Risk Factor for Fracture in Older Adults
Australian investigators found a 14% higher risk of fracture for every 1-SD increment in level of HDL-C in community dwelling healthy adults aged ≥70 years.
Daily Dose: Comparison of Loop Diuretics Shows No Difference in Heart Failure Survival
KDIGO 2022 Diabetes Management in CKD Guideline: A Topline Look at the Focused Update
This topline look at the KDIGO 2022 updated guideline highlights new recommendations for clinical use of SGLT2i, GLP-1 RA, and nonsteroidal MRA.
Number and Size of Daily Meals, Not Intermittent Fasting, Associated with Long-term Weight Loss in New Study
When counseling patients about weight gain prevention, limiting the frequency of larger meals is more beneficial than time-restricted eating, advised authors.
Pediatric Cannabis Poisoning Hospitalizations Doubled in Canada After Legalization of Edibles: Study
Ingestion of cannabis is now the cause of 1 in every 3 pediatric poisoning hospitalizations in Canadian provinces where edibles are sold legally.
Daily Dose: Most Long COVID Outcomes Resolve in 1 Year After Mild Infection
